Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for CN+ Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

159

Participants

Timeline

Start Date

September 24, 2020

Primary Completion Date

December 2, 2022

Study Completion Date

May 24, 2023

Conditions
Location and Biopsy of Axillary Lymph Nodes
Interventions
DRUG

Carbon nanoparticles suspension injection will be injected into or around the cortex of the clinically assessed positive lymph nodes

Before NST, one of the clinically assesed positive lymph nodes will be subjected to ultrasound-guided CNB or FNA, and a locating clip (Ultraclip, BARD) will be placed. Meanwhile, a small amount of Kanarine (carbon nanoparticles suspension injection, 0.5ml:25mg, H20073246) will be injected into or around the cortex of the locating lymph node and other clinically assessed positive lymph nodes. Preoperative FNA will be performed again for locating clip labelled node.

Trial Locations (1)

210009

the First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER

NCT04482803 - Targeted Biopsy of Carbon Nanoparticles Labelled Axillary Node for CN+ Breast Cancer | Biotech Hunter | Biotech Hunter